Corsevin M

Drug Profile

Corsevin M

Alternative Names: 12D-10Fab; CVS-12D10

Latest Information Update: 11 Jun 2000

Price : $50

At a glance

  • Originator Unknown
  • Class Anticoagulants; Antithrombotics; Monoclonal antibodies
  • Mechanism of Action Factor VIIa inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Arterial thrombosis; Disseminated intravascular coagulation; Unstable angina pectoris

Most Recent Events

  • 11 Jun 2000 Discontinued-II for Arterial thrombosis in USA (IV-injection)
  • 11 Jun 2000 Discontinued-II for Disseminated intravascular coagulation in USA (IV-injection)
  • 11 Jun 2000 Discontinued-II for Unstable angina pectoris in USA (IV-injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top